- Member of Turkish Medical Association, Turkish Society of Nuclear Medicine, The Society of Nuclear Medicine, European Society of Nuclear Medicine and American Society of Nuclear Cardiology.
- 31 articles published in international scientific journals and 8 articles published in national journals which included in the SCI (Science Citation Index)
- Principal fields of clinical interest:
- Radioiodine treatment in cases of thyroid cancer and hyperthyroidism,
- Treatment of advanced metastatic thyroid cancers,
- Treatment of radioiodine-refractory metastatic thyroid cancers,
- Lu-177 /Ac-225 PSMA inh treatment for patients with metastatic prostate cancer; pioneering national practitioner, pioneer in Europe along with several centers,
- Lu-177 / Y-90 octreotide and octreotate treatment in metastatic neuroendocrine tumors,
- Radio-embolization (TARE) in cases of primary/metastatic liver cancer,
- Ra-223 dichloride treatment in metastatic bone disease,
- I-131 MIBG treatment in cases of metastatic neuroblastoma/pheochromocytoma,
- Lu-177 CXCR4 (chemokine receptor type 4) treatment in cases of refractory multiple myeloma.